Literature DB >> 11883639

Size-dependency of DL-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium.

Eijiro Horisawa1, Katsuaki Kubota, Izumi Tuboi, Keiichi Sato, Hiromitsu Yamamoto, Hirofumi Takeuchi, Yoshiaki Kawashima.   

Abstract

PURPOSE: The present study evaluated the size-dependency of DL lactide/glycolide copolymer (PLGA) particulates for an intra articular delivery system on phagocytosis in the rat synovium after administering directly into the joint cavity. We also investigated the biocompatibility of PLGA particulate systems administered directly into the joint cavity of the rat.
METHODS: Fluoresceinamine bound PLGA (FA-PLGA) nanospheres and microspheres were prepared by the modified emulsion solven diffusion method. The suspension of these particulate systems was administered into the rat-joint cavity and the biological action of the synovium was evaluated by histological inspection and fluorescence microscopy.
RESULTS: A colloidal suspension of the FA-PLGA nanospheres, with a mean diameter of 265 nm, was phagocytosed in the synovium by the macrophages infiltrated through the synovial tissues. The phagocytosed nanospheres were delivered to the deep underlying tissues. An aqueous suspension of the FA-PLGA microspheres, with a mean diameter of 26.5 microm, was not phagocytosed in the macrophages. The macrophages slightly proliferated in the epithelial lining synovial-cells and the microspheres were covered with a granulation of multinucleated giant cells. The molecular weights of the polymer in these particulate systems were slowly reduced in the synovium. Localize inflammatory responses were almost undetected.
CONCLUSIONS: PLGA nanospheres should be more suitable for delivery to inflamed synovial tissue than microspheres due to their ability to penetrate the synovium. PLGA particulate systems with biocompatibility in the joint can provide local-therapy action in joint disease in a different manner depending on the size of the system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11883639     DOI: 10.1023/a:1014260513728

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods.

Authors:  Y Kawashima; H Yamamoto; H Takeuchi; T Hino; T Niwa
Journal:  Eur J Pharm Biopharm       Date:  1998-01       Impact factor: 5.571

2.  Size-dependency of DL-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium.

Authors:  Eijiro Horisawa; Katsuaki Kubota; Izumi Tuboi; Keiichi Sato; Hiromitsu Yamamoto; Hirofumi Takeuchi; Yoshiaki Kawashima
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

3.  Macrophage targeting with 99mTc-labelled J001 for scintigraphy of joint inflammation in ovalbumin-induced arthritis in rabbits.

Authors:  P Goupille; F Perin; J P Valat; A Le Pape
Journal:  Clin Exp Rheumatol       Date:  1997 May-Jun       Impact factor: 4.473

4.  Liposome-incorporated corticosteroids. II. Therapeutic activity in experimental arthritis.

Authors:  N C Phillips; D P Thomas; C G Knight; J T Dingle
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

5.  Albumin microspheres for intra-articular drug delivery: investigation of their retention in normal and arthritic knee joints of rabbits.

Authors:  J H Ratcliffe; I M Hunneyball; C G Wilson; A Smith; S S Davis
Journal:  J Pharm Pharmacol       Date:  1987-04       Impact factor: 3.765

6.  Macrophage/particle interactions: effect of size, composition and surface area.

Authors:  A S Shanbhag; J J Jacobs; J Black; J O Galante; T T Glant
Journal:  J Biomed Mater Res       Date:  1994-01

7.  A highly topically active corticosteroid. Preliminary report.

Authors:  Y Mizushima; H Miyake; K Fujiwara; N Ono; K Takikawa
Journal:  Arzneimittelforschung       Date:  1980

8.  Ultrastructural study of cells at the synovium-cartilage junction: response of synovial cells of the rat knee joint to intra-articularly injected latex particles.

Authors:  H Senda; E Sakuma; I Wada; H J Wang; H Maruyama; N Matsui
Journal:  Kaibogaku Zasshi       Date:  1999-10

9.  Preparation and testing of cyclosporine microsphere and solution formulations in the treatment of polyarthritis in rats.

Authors:  M D'Souza; P DeSouza
Journal:  Drug Dev Ind Pharm       Date:  1998-09       Impact factor: 3.225

10.  Gelatin/chondroitin 6-sulfate microspheres for the delivery of therapeutic proteins to the joint.

Authors:  K E Brown; K Leong; C H Huang; R Dalal; G D Green; H B Haimes; P A Jimenez; J Bathon
Journal:  Arthritis Rheum       Date:  1998-12
View more
  39 in total

1.  Nanoengineered particles for enhanced intra-articular retention and delivery of proteins.

Authors:  Ankur Singh; Rachit Agarwal; Carlos A Diaz-Ruiz; Nick J Willett; Peiyi Wang; L Andrew Lee; Qian Wang; Robert E Guldberg; Andrés J García
Journal:  Adv Healthc Mater       Date:  2014-03-31       Impact factor: 9.933

2.  Synthesis and characterization of silk fibroin microparticles for intra-articular drug delivery.

Authors:  Timothy K Mwangi; Robby D Bowles; David M Tainter; Richard D Bell; David L Kaplan; Lori A Setton
Journal:  Int J Pharm       Date:  2015-02-24       Impact factor: 5.875

3.  Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery.

Authors:  Huanyu Dou; Christopher J Destache; Justin R Morehead; R Lee Mosley; Michael D Boska; Jeffrey Kingsley; Santhi Gorantla; Larisa Poluektova; Jay A Nelson; Mahesh Chaubal; Jane Werling; James Kipp; Barrett E Rabinow; Howard E Gendelman
Journal:  Blood       Date:  2006-06-29       Impact factor: 22.113

4.  Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis.

Authors:  Ambika G Bajpayee; Cliff R Wong; Moungi G Bawendi; Eliot H Frank; Alan J Grodzinsky
Journal:  Biomaterials       Date:  2013-10-10       Impact factor: 12.479

5.  Nanoparticle Properties for Delivery to Cartilage: The Implications of Disease State, Synovial Fluid, and Off-Target Uptake.

Authors:  Shannon Brown; Jake Pistiner; Isaac M Adjei; Blanka Sharma
Journal:  Mol Pharm       Date:  2018-12-31       Impact factor: 4.939

6.  Intra-articular clearance of labeled dextrans from naive and arthritic rat knee joints.

Authors:  Timothy K Mwangi; Ian M Berke; Eduardo H Nieves; Richard D Bell; Samuel B Adams; Lori A Setton
Journal:  J Control Release       Date:  2018-05-26       Impact factor: 9.776

Review 7.  Strategies for controlled delivery of biologics for cartilage repair.

Authors:  Johnny Lam; Steven Lu; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2014-06-30       Impact factor: 15.470

Review 8.  Immunosuppressive and anti-inflammatory properties of engineered nanomaterials.

Authors:  A N Ilinskaya; M A Dobrovolskaia
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

9.  Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery.

Authors:  Deepa A Rao; M Laird Forrest; Adam W G Alani; Glen S Kwon; Joseph R Robinson
Journal:  J Pharm Sci       Date:  2010-04       Impact factor: 3.534

Review 10.  Evaluating intra-articular drug delivery for the treatment of osteoarthritis in a rat model.

Authors:  Kyle D Allen; Samuel B Adams; Lori A Setton
Journal:  Tissue Eng Part B Rev       Date:  2010-02       Impact factor: 6.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.